United States Drug Testing Laboratories Sold to Northlane Capital Partners
Deal News | Jan 13, 2025 | Brown Gibbons Lang and Company (BGL)
Brown Gibbons Lang & Company, a prominent investment bank and financial advisory firm, has successfully advised on the sale of United States Drug Testing Laboratories Inc. (USDTL), a notable forensic toxicology laboratory, to Northlane Capital Partners. This transaction highlights BGL's capabilities in facilitating strategic deals within the forensic toxicology and financial services sectors. USDTL is an established name in forensic toxicology, providing specialized testing services. The acquisition by Northlane Capital Partners signifies a strategic expansion and investment focus in this sector, emphasizing the growing importance of such laboratory services.
Sectors
- Forensic Toxicology
- Financial Services
- Private Equity
Geography
- United States – The operations and location of USDTL and the primary geographical focus of the transaction.
Industry
- Forensic Toxicology – The industry relevant to USDTL, which specializes in providing forensic toxicology testing services.
- Financial Services – Brown Gibbons Lang & Company operates within this sector as an investment bank and financial advisory firm.
- Private Equity – Northlane Capital Partners operates within this industry, acquiring companies like USDTL.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| United States Drug Testing Laboratories Inc. (USDTL) | Target | Company | A leading forensic toxicology laboratory sold in the transaction. |
| Brown Gibbons Lang & Company (BGL) | Advisor | Company | A leading independent investment bank and financial advisory firm facilitating the transaction. |
| Northlane Capital Partners | Buyer | Company | A private equity firm acquiring USDTL. |